tiprankstipranks
Coloplast A/S (GB:0QBO)
LSE:0QBO

Coloplast A/S (0QBO) Income Statement

11 Followers

Coloplast A/S Income Statement

Last quarter (Q1 2023), Coloplast A/S's total revenue was kr6.11B, an increase of 18.11% from the same quarter last year. In Q1, Coloplast A/S's net income was kr1.13B. See Coloplast A/S’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Sep 23Sep 22Sep 21Sep 20Sep 19
Total Revenue
kr 23.52B-kr 22.58Bkr 19.43Bkr 18.54Bkr 17.94B
Cost of Revenue
kr 7.37B-kr 7.05Bkr 6.11Bkr 5.93Bkr 5.79B
Gross Profit
kr 16.14B-kr 15.53Bkr 13.31Bkr 12.61Bkr 12.15B
Operating Expense
kr 9.11B-kr 8.62Bkr 6.96Bkr 6.76Bkr 6.60B
Operating Income
kr 7.04B-kr 6.91Bkr 6.36Bkr 5.85Bkr 5.56B
Net Non Operating Interest Income Expense
kr -312.00M-kr -224.00Mkr -45.00Mkr -54.00Mkr -34.00M
Other Income Expense
------
Pretax Income
kr 6.00B-kr 6.13Bkr 6.23Bkr 5.47Bkr 5.03B
Tax Provision
kr 1.37B-kr 1.42Bkr 1.41Bkr 1.27Bkr 1.16B
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
kr 4.63B-kr 4.71Bkr 4.83Bkr 4.20Bkr 3.87B
Basic EPS
------
Diluted EPS
------
Basic Average Shares
------
Diluted Average Shares
------
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
kr 16.48B-kr 15.67Bkr 13.07Bkr 12.69Bkr 12.38B
Net Income From Continuing And Discontinued Operation
kr 4.63B-kr 4.71Bkr 4.83Bkr 4.20Bkr 3.87B
Normalized Income
kr 5.00B-kr 5.19Bkr 4.97Bkr 4.26Bkr 4.25B
Interest Expense
kr 431.00M-kr 172.00Mkr 25.00Mkr 30.00Mkr 6.00M
EBIT
kr 6.43B-kr 6.30Bkr 6.26Bkr 5.50Bkr 5.03B
EBITDA
kr 7.44Bkr 7.73Bkr 7.23Bkr 7.05Bkr 6.35Bkr 5.68B
Currency in DKK

Coloplast A/S Earnings and Revenue History

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis